DMH2 T25346
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
DMH2 is an antagonist of bone morphogenetic protein (BMP) type I receptor. It acts by decreasing growth and inducing cell death of lung cancer cell lines.
CAS nr:
1206711-14-9
Purity:
98%
Molecular Weight:
451,53
SMILES:
N1(CCOC2=CC=C(C3=CN4C(N=C3)=C(C5=CC=NC6=CC=CC=C56)C=N4)C=C2)CCOCC1
Formula:
C27H25N5O2
Pathway:
Target:
